National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?
作者信息
Krishnan Jerry A, Cloutier Michelle M, Schatz Michael
机构信息
University of Illinois at Chicago Chicago, Illinois.
UCONN Health Farmington, Connecticut and.
出版信息
Am J Respir Crit Care Med. 2021 Jan 15;203(2):164-167. doi: 10.1164/rccm.202011-4236ED.
Abstract
摘要
相似文献
1
National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?
Am J Respir Crit Care Med. 2021 Jan 15;203(2):164-167. doi: 10.1164/rccm.202011-4236ED.
2
NIH News: update from the National Asthma Education and Prevention Program 2002.
Manag Care. 2003 Jan;12(1 Suppl):5-10.
3
A cure for asthma.
N Z Med J. 2016 Nov 18;129(1445):8-10.
4
Kids' asthma management program increases use of guideline-recommended drugs.
Rep Med Guidel Outcomes Res. 2002 Oct 4;13(19):9-10, 12.
5
Update in Asthma 2019.
Am J Respir Crit Care Med. 2020 Jul 15;202(2):184-192. doi: 10.1164/rccm.202003-0596UP.
6
Implementing the guidelines: What do you do when the rubber hits the road?
J Allergy Clin Immunol. 2020 Dec;146(6):1271-1274. doi: 10.1016/j.jaci.2020.10.010.
7
Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program.
MMWR Recomm Rep. 2003 Mar 28;52(RR-6):1-8.
8
From the page to the clinic: Implementing new National Asthma Education and Prevention Program guidelines.
Clin Cornerstone. 2009;9(3):9-19. doi: 10.1016/s1098-3597(09)80008-2.
9
Asthma--the shift from episodic treatment to ongoing prevention, education, and management.
West J Med. 1998 Dec;169(6):377.
10
Turkish Thoracic Society asthma management and prevention guideline: key points.
Tuberk Toraks. 2011;59(3):291-311.
引用本文的文献
1
Determination of pediatric asthma severity using retrospective electronic health record prescription data: an analysis before and after the 2020 national asthma education and prevention program guideline update.
J Asthma. 2025 Jun 10:1-11. doi: 10.1080/02770903.2025.2514265.
2
The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17.
3
Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2767-2777. doi: 10.1016/j.jaip.2023.05.023. Epub 2023 May 26.
4
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
Am J Respir Crit Care Med. 2023 Feb 15;207(4):390-405. doi: 10.1164/rccm.202209-1729PP.
本文引用的文献
1
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.
J Allergy Clin Immunol. 2020 Dec;146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003.
2
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.
J Biopharm Stat. 2020 Nov 1;30(6):1026-1037. doi: 10.1080/10543406.2020.1821705. Epub 2020 Sep 17.
3
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
Lancet Respir Med. 2020 Jul;8(7):671-680. doi: 10.1016/S2213-2600(20)30053-9. Epub 2020 Mar 11.
4
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.00588-2019. Print 2020 Jan.
5
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.
Eur Respir J. 2019 Jun 27;53(6). doi: 10.1183/13993003.01046-2019. Print 2019 Jun.
6
Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.
N Engl J Med. 2019 May 23;380(21):2009-2019. doi: 10.1056/NEJMoa1814917. Epub 2019 May 19.
7
Generating evidence to inform an update of asthma clinical practice guidelines: Perspectives from the National Heart, Lung, and Blood Institute.
J Allergy Clin Immunol. 2018 Sep;142(3):744-748. doi: 10.1016/j.jaci.2018.07.004. Epub 2018 Jul 21.
8
Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.
JAMA. 2018 Apr 10;319(14):1441-1443. doi: 10.1001/jama.2018.2029.
9
Living systematic reviews: 4. Living guideline recommendations.
J Clin Epidemiol. 2017 Nov;91:47-53. doi: 10.1016/j.jclinepi.2017.08.009. Epub 2017 Sep 11.
Zotero 插件